Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Adler

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 24, 2024
Vaporized Hydogen Peroxide Uptake by Tubing used for Aseptic Fill-Finish Manufacturing of Biopharmaceutical Drug ProductsDilara Ali, Sarah S Peláez, Thomas Lemazurier, et al.
Journal of Pharmaceutical Sciences|August 18, 2012
Analytical protein a chromatography as a quantitative tool for the screening of methionine oxidation in monoclonal antibodiesCaroline Loew, Constanze Knoblich, Jürgen Fichtl, et al.
Analytical Chemistry|May 23, 2015
Measuring Subvisible Particles in Protein Formulations Using a Modified Light Obscuration Sensor with Improved Detection CapabilitiesAnacelia Ríos Quiroz, Gabriela Québatte, Fabian Stump, et al.
Chemico-Biological Interactions|January 24, 2006
Inhibition of guinea pig hemi-diaphragm acetylcholinesterase activity by pyridostigmine bromide and protection against soman toxicityJulian R Haigh, Scott R Johnston, Brian M Peters, et al.
Pharmaceutical Research|October 18, 2015
Factors Governing the Precision of Subvisible Particle Measurement Methods - A Case Study with a Low-Concentration Therapeutic Protein Product in a Prefilled SyringeAnacelia Ríos Quiroz, Jens Lamerz, Thierry Da Cunha, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 15, 2015
The pharmaceutical vial capping process: Container closure systems, capping equipment, regulatory framework, and seal quality testsRoman Mathaes, Hanns-Christian Mahler, Jean-Pierre Buettiker, et al.
Chemico-Biological Interactions|February 11, 2010
Protection by pyridostigmine bromide of marmoset hemi-diaphragm acetylcholinesterase activity after soman exposureJulian R Haigh, Michael Adler, James P Apland, et al.
FEBS Letters|March 21, 2002
Development of a delivery vehicle for intracellular transport of botulinum neurotoxin antagonistsMichael C Goodnough, George Oyler, Paul S Fishman, et al.
Hepatology (Baltimore, Md.)|October 14, 2009
The cirrhosis risk score predicts liver fibrosis progression in patients with initially mild chronic hepatitis CPierre Pradat, Eric Trepo, Andrej Potthoff, et al.
Plos Pathogens|July 11, 2014
Widespread sequence variations in VAMP1 across vertebrates suggest a potential selective pressure from botulinum neurotoxinsLisheng Peng, Michael Adler, Ann Demogines, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 24, 2024
Vaporized Hydogen Peroxide Uptake by Tubing used for Aseptic Fill-Finish Manufacturing of Biopharmaceutical Drug ProductsDilara Ali, Sarah S Peláez, Thomas Lemazurier, et al.
Journal of Pharmaceutical Sciences|August 18, 2012
Analytical protein a chromatography as a quantitative tool for the screening of methionine oxidation in monoclonal antibodiesCaroline Loew, Constanze Knoblich, Jürgen Fichtl, et al.
Analytical Chemistry|May 23, 2015
Measuring Subvisible Particles in Protein Formulations Using a Modified Light Obscuration Sensor with Improved Detection CapabilitiesAnacelia Ríos Quiroz, Gabriela Québatte, Fabian Stump, et al.
Chemico-Biological Interactions|January 24, 2006
Inhibition of guinea pig hemi-diaphragm acetylcholinesterase activity by pyridostigmine bromide and protection against soman toxicityJulian R Haigh, Scott R Johnston, Brian M Peters, et al.
Pharmaceutical Research|October 18, 2015
Factors Governing the Precision of Subvisible Particle Measurement Methods - A Case Study with a Low-Concentration Therapeutic Protein Product in a Prefilled SyringeAnacelia Ríos Quiroz, Jens Lamerz, Thierry Da Cunha, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 15, 2015
The pharmaceutical vial capping process: Container closure systems, capping equipment, regulatory framework, and seal quality testsRoman Mathaes, Hanns-Christian Mahler, Jean-Pierre Buettiker, et al.
Chemico-Biological Interactions|February 11, 2010
Protection by pyridostigmine bromide of marmoset hemi-diaphragm acetylcholinesterase activity after soman exposureJulian R Haigh, Michael Adler, James P Apland, et al.
FEBS Letters|March 21, 2002
Development of a delivery vehicle for intracellular transport of botulinum neurotoxin antagonistsMichael C Goodnough, George Oyler, Paul S Fishman, et al.
Hepatology (Baltimore, Md.)|October 14, 2009
The cirrhosis risk score predicts liver fibrosis progression in patients with initially mild chronic hepatitis CPierre Pradat, Eric Trepo, Andrej Potthoff, et al.
Plos Pathogens|July 11, 2014
Widespread sequence variations in VAMP1 across vertebrates suggest a potential selective pressure from botulinum neurotoxinsLisheng Peng, Michael Adler, Ann Demogines, et al.
Pageof 11